|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1300 I Street, NW |
Address2 | Suite 525 West |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Woonsocket |
State | RI |
Zip Code | 20895 |
Country | USA |
|
5. Senate ID# 302778-1003157
|
||||||||
|
6. House ID# 394420000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Russell C. Ring, SVP-Government Affairs |
Date | 10/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Care Reform-Issues relating to comprehensive health care reform, insurance reforms, delivery system, expanding coverage for the uninsured, and increasing health care value. Other specific issues include PBM disclosure requirements, generic drug reimbursement under Medicaid, tax issues, changes to Medicare Part D and prevention & wellness issues.
H.R. 3200 Americas Affordable Health Choices Act of 2009
S. 1679 Affordable Health Choices Act
Americas Healthy Future Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Generics Issues/Biologics-Expanding access to generic drugs and creating an FDA pathway to bring generic versions of biologics to market; realignment of incentives for generic manufacturers to challenge brand patents for earlier market entry.
H.R. 1706 - Protecting Consumer Access to Generic Drugs Act of 2009
H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act
S.726 - Promoting Innovation and Access to Life-Saving Medicine Act
S. 1315-Drug Price Competition Act of 2009
H.R. 1548 - Pathway for Biosimilars Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Workforce-Issues related to recommendations for the reauthorization of the WIA including increasing employer involvement and ways to increase the success of these programs. Issues relating to a proposed anti-trust exemption for certain pharmacies, healthcare competition and the CVS Caremark business model.Card Check/Labor-Issues relating to unionization in the workplace.
Workforce Investment Act reauthorization
H.R. 1204 - Community Pharmacy Fairness Act of 2009
H.R. 1409 - Employee Free Choice Act of 2009
S. 560 - Employee Free Choice Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Food Safety-Issues related to the proposed increased food safety requirements
S. 510 - FDA Food Safety Modernization Act
H.R. 1332 Safe FEAST Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare/Medicaid-Changes to the Medicare and Medicaid programs, including rebate structures and formularies, coverage, pharmacy reimbursement for generic drugs under Medicaid, disclosure of PBM information and the Medicare DME program.
H.R. 3200 - America's Affordable Health Choices Act of 2009
America's Healthy Future Act of 2009
S. 956/H.R. 1970-Preserve Patient Access to Reputable DMEPOS Providers Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Issues related to potential changes to drug benefits offered under FEHBP.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |